M.A. Med Alliance is the lead sponsor of 6 current clinical trials in our USA and UK registers. 1 is recruiting patients now. All registered phases are Not applicable. The most-studied condition is Coronary Artery Disease.
| Study | Phase | Status | Start | Registers |
|---|---|---|---|---|
|
SELUTION4BTK Trial
NCT05055297 · ClinicalTrials.gov ↗ · Peripheral Arterial Disease, Chronic Limb-Threatening Ischemia Nos of Native Arteries of Extremities
|
Not applicable | Recruiting | 2022-05 | USA |
|
SUCCESS (SelUtion, Safety, effiCaCy, hEalth economicS and promS) PTA Study
NCT04776434 · ClinicalTrials.gov ↗ · Peripheral Artery Disease
|
Not applicable | Active, closed | 2021-02 | UK |
|
SELUTION 4 De Novo Small Vessel IDE Trial
NCT05946629 · Coronary Artery Disease
|
Not applicable | Active, closed | 2023-10 | USA |
|
SELUTION4SFA Trial
NCT05132361 · Peripheral Arterial Disease, Superficial Femoral Artery Stenosis
|
Not applicable | Active, closed | 2022-12 | USA |
|
The SELUTION DeNovo Study
NCT04859985 · ClinicalTrials.gov ↗ · Coronary Artery Disease
|
Not applicable | Active, closed | 2021-05 | UK |
|
SELUTION SLR™ 014 In-stent Restenosis
NCT04280029 · ClinicalTrials.gov ↗ · Coronary Restenosis
|
Not applicable | Active, closed | 2020-07 | USA |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.
| Register | Trials | Recruiting |
|---|---|---|
| Clinical trials in USA | 4 | 1 |
| Clinical trials in UK | 2 | 0 |
A trial with sites in more than one country appears in each of those registers.
Sponsors with the most current trials registered for this condition.
M.A. Med Alliance is the lead sponsor of 6 current trials on ClinicalTrials.gov in our USA and UK registers, as of the registry sync on 26 September 2026. Completed and withdrawn studies are not counted.
Yes. 1 of its 6 ClinicalTrials.gov trials is recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.
Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.
Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 26 Sep 2026.